Moscow to bet $577M on tech ventures

The Kremlin opened bidding this week on a new venture-capital programme to kick-start the country’s technology sector. And it starts with full pockets.

Gene therapy gets big pharma endorsement

Gene therapy is poised to make a commercial breakthrough after Oxford BioMedica agreed global rights for a cancer treatment with Sanofi-Aventis, in a deal with a headline value of €518 million.